Oncoplastic approach in the conservative treatment of breast cancer: analysis of costs.
OBJECTIVE
To analyze the direct costs of conservative surgical treatment of breast cancer, performed in a university hospital, to the Brazilian National Health Care Public System (SUS), checking the impact of the oncoplastic approach on these costs.


METHODS
One hundred thirty eight breast cancer patients who had undergone conservative treatment with oncoplastic approach (n=36) or not (control group, n=102), in the period from 2005 to 2010, were enrolled. Sociodemographic and clinical data were recorded. The direct costs of the surgical procedure were obtained and analyzed.


RESULTS
Groups did not differ in regard to age (p=0.963), and patients in oncoplastic group had a longer time of hospital stay (p=0.000). The median direct cost for the oncoplastic group was R$461.00 and for the control group was R$229.00 (p=0.000).


CONCLUSIONS
The oncoplastic approach has generated higher direct costs in conservative surgical treatment of breast cancer to SUS.
School of Medical Sciences, UNIVÁS, Pouso Alegre-MG, Brazil.
Débora Eleotério de
DE
Lima
Joel
J
Veiga Filho
Leda Marques
LM
Ribeiro
Thiago Bezerra de
TB
Morais
Luiz Roberto Martins
LR
Rocha
Yara
Y
Juliano
Daniela Francescato
DF
Veiga
Lydia Masako
LM
Ferreira
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001938:Brazil; D001943:Breast Neoplasms / Q000191:economics / Q000601:surgery*; D005260:Female; D006801:Humans; D016462:Mammaplasty / Q000191:economics* / Q000379:methods; D015412:Mastectomy, Segmental / Q000191:economics* / Q000379:methods; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics; D013518:Surgery, Plastic; D016896:Treatment Outcome; D055815:Young Adult